REPORT: Procarbazine, dacarbazine may up stomach cancer risk in Hodgkin's
This article was originally published in Scrip
Executive Summary
Patients with Hodgkin lymphoma treated with high doses of radiation to the stomach had nearly a threefold greater risk of developing stomach cancer than those who received the lowest doses.